Total Laparoscopic Hysterectomy using a new hand activated advanced bipolar device, the HALO™ PKS™ Cutting Forceps
Dr. Rosenblatt demonstrates the use of a new hand-activated advanced bipolar device, the HALO™ (Hand Activation for Laparoscopy and Open) PKS™ Cutting Forceps. The HALO™ PKS™ Cutting Forceps is the latest advancement in the PK® technology platform that provides the surgeon with hand activated control in one ergonomic handle. In this Total Laparoscopic Hysterectomy procedure, the HALO is used to coagulate and divide the pedicles. The PKS™ PlasmaSpatula®, an advanced bipolar cut and bipolar coagulation device, is used for the colpotomy.
Dr. Rosenblatt is paid by Gyrus ACMI, Inc. for his consulting services for courses and didactic lectures and received financial support from Gyrus ACMI, Inc. for the clinical video on this website.
Important Note to Reader: The information in these Web pages is for your general knowledge and background only. Note that these Web pages contain information from various sources considered to be dependable. However, we make no representations, warranties or other expressed or implied warranties or guarantees regarding the accuracy, reliability or completeness of the information. Under no circumstance shall Gyrus ACMI, Inc., Olympus America Inc. and/or its or their respective affiliates, employees, consultants, agents or representatives (collectively "Gyrus") be liable for any costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be in incurred in connection with the information provided or any use thereof.
© 2010 Gyrus ACMI, Inc. All rights reserved. | Privacy Policy | Legal Notice
Advancing obstetric and gynecologic surgery through robotic innovation
April 30th 2024Explore how robotic surgery revolutionizes obstetric and gynecologic procedures, offering enhanced precision, reduced complications, and improved patient outcomes, while also examining challenges and future prospects in the field.
Read More
Unlocking placenta accreta spectrum with single-cell gene targets
April 18th 2024Discover how cutting-edge single-cell RNA sequencing unveils molecular insights into placenta accreta spectrum disorders, potentially revolutionizing diagnostics and treatments for this life-threatening pregnancy complication.
Read More
Excessive gonadotropins in IVF: Effects on mosaicism and live birth
April 12th 2024A recent study revealed a correlation between high doses and prolonged duration of exogenous gonadotropin use during in vitro fertilization and increased embryonic mosaicism alongside diminished live birth rates, prompting reconsideration of dosage and duration protocols.
Read More
Maternal history linked to uterine fibroid risk in Black women
April 11th 2024Delve into the findings of a recent study revealing the heightened risk of developing uterine fibroids among Black women with a maternal history of the condition, shedding light on crucial implications for patient care and advocacy.
Read More